The generic name of Vedolizumab is Vedolizumab for Injection, which can be used for the treatment of ulcerative colitis and Crohn’s disease. null1. Treatment of Ulcerative Colitis: This product is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to, or have failed to respond to, or are intolerant of, conventional therapy or tumor necrosis factor alpha (TNFα) inhibitors. null2. 2. Treatment of Crohn’s Disease: This product is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, failure to respond, or intolerance to conventional therapy or TNFα inhibitors. Vedelizumab is the only anti-inflammatory humanized monoclonal antibody drug, but some patients may experience side effects such as allergies, infections, and liver damage after using Vedelizumab. Be sure to take the medication under your doctor’s supervision to avoid adverse reactions. Before receiving vedolizumab treatment, you must go to a regular hospital to receive treatment, and make clear whether you have suffered from underlying diseases in the past or at present, such as tuberculosis, hepatitis B, hypertension, diabetes and other diseases, as well as whether you are in the period of pregnancy, breastfeeding, or preparing for pregnancy.